dressing alginate cavity wound (Kaltostat 168117)
What to know about dressing alginate cavity wound — also sold as Kaltostat 168117, Comfeel SeaSorb Filler 3740, Sorbsan 1411: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
dressing alginate cavity wound (brand names: Kaltostat 168117, Comfeel SeaSorb Filler 3740, Sorbsan 1411) is classified as Minimal risk by AllMeds. Non-therapeutic wound dressing with no systemic absorption or pharmacological effects.
Key Takeaways
- Risk level: Minimal (0 points)
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | Unscheduled | PBS listed |
Risk Profile
Non-therapeutic wound dressing with no systemic absorption or pharmacological effects.
How dressing alginate cavity wound is regulated
dressing alginate cavity wound is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Australia TGA / PBS / State Schemes
Classified as Unscheduled under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
Check this medication against your full medication list
Run a full risk assessment including dressing alginate cavity wound interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.